-
-
-
-
-
-
-
MERGER ALERT - ADMS, AZPN, and FLXN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
-
-
-
-
-
-
-
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
-
-
-
-
-
-
-
Flexion Therapeutics (FLXN), Xenon Pharmaceuticals (XENE) Announce Flexion's Acquisition of Investigational NaV1.7 Inhibitor for Treatment of Post-Operative Pain
-
-
-
-
-
-
-
Flexion Therapeutics (FLXN) Buys Novel, Non-Opioid Asset for Osteoarthritis of the Knee
-
-
-
-
-
-
-
Flexion Therapeutics (FLXN) Announces Proposed Convertible Senior Notes Offering
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 5/26: (NERV) (FLXN) (SKIS) Higher; (IONS) (PRGN) (TDW) Lower
-
-
-
-
-
-
-
Flexion Therapeutics Awarded Approximately $2 Million From U.S. Department of Defense to Conduct Clinical Trial of FX006 in Military Personnel With Osteoarthritis of the Knee
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

